<?xml version="1.0" encoding="UTF-8"?>
<ref id="B34-molecules-25-00675">
 <label>34.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Klauke</surname>
    <given-names>A.L.</given-names>
   </name>
   <name>
    <surname>Racz</surname>
    <given-names>I.</given-names>
   </name>
   <name>
    <surname>Pradier</surname>
    <given-names>B.</given-names>
   </name>
   <name>
    <surname>Markert</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Zimmer</surname>
    <given-names>A.M.</given-names>
   </name>
   <name>
    <surname>Gertsch</surname>
    <given-names>J.</given-names>
   </name>
   <name>
    <surname>Zimmer</surname>
    <given-names>A.</given-names>
   </name>
  </person-group>
  <article-title>The cannabinoid CB
   <sub>2</sub> receptor-selective phytocannabinoid beta-caryophyllene exerts analgesic effects in mouse models of inflammatory and neuropathic pain
  </article-title>
  <source>Eur. Neuropsychopharmacol.</source>
  <year>2014</year>
  <volume>24</volume>
  <fpage>608</fpage>
  <lpage>620</lpage>
  <pub-id pub-id-type="doi">10.1016/j.euroneuro.2013.10.008</pub-id>
  <pub-id pub-id-type="pmid">24210682</pub-id>
 </element-citation>
</ref>
